Don't think of Reliance Steel & Aluminum (NYSE: RS) as a steel company; think of it as a 'diversified' metals company, and one that's on sale, at that.
Reliance supplies metal process services and also manufactures metal products for the construction, transportation, aerospace, manufacturing and semiconductor industries.
Reliance is a compelling play now primarily for three reasons: 1) its demonstrated proficiency servicing the aforementioned sectors, 2) the continued strength of the international economy, and 3) the high-end nature of the company's metal products. That last point provides an element of safety for investors: don't think of RS as a classic "basic steel for building foundations" company. Reliance has a multitude of products that are outside the classic (and very cyclical) office building segment. A telling fact: Reliance serves more than 125,000 customers.
Further, the argument among some analysts that above-average prices for steel and aluminum are not sustainable is not supported by current global economic conditions. True, due to the slumping auto industry, U.S. demand may drop, but demand from China and from Asia, in general, remains strong, and Latin America is expected to hold up its end of the bargain in 2008. The Reuters F2007/F2008 EPS consensus estimates for RS are $5.32/$6.02.
The First Call mean rating for RS is: Buy. [8 firms.] Mean 2007 target: $67.50. [high: $77, low: $59.]
Further, investors can receive an added savings as a result of Thursday's market sell-off: RS's shares closed Thursday down $1.60 to $56.75. RS's low p/e of 10 also reduces the stock's risk/return ratio, and it's a modest price to play for such a well-run company with in-demand products.
Stock Analysis: Reliance is a moderate-risk stock not suitable for low-risk investors. Investors with an investment horizon longer than 2 years should be rewarded from RS's shares. Sell / Stop Loss: $39.
Last updated: February 13, 2012: 04:26 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
11-04-2007 @ 7:36AM
jaiprakash said...
i m science graduate in b.sc( p.c.m) whats is the jobs scope in in urs company